Literature DB >> 31171723

Tau isoform expression and phosphorylation in marmoset brains.

Govinda Sharma1, Anni Huo1, Taeko Kimura1,2, Seiji Shiozawa3, Reona Kobayashi3,4, Naruhiko Sahara2, Minaka Ishibashi5, Shinsuke Ishigaki5, Taro Saito1, Kanae Ando1, Shigeo Murayama6, Masato Hasegawa7, Gen Sobue5, Hideyuki Okano3,4, Shin-Ichi Hisanaga8,7.   

Abstract

Tau is a microtubule-associated protein expressed in neuronal axons. Hyperphosphorylated tau is a major component of neurofibrillary tangles, a pathological hallmark of Alzheimer's disease (AD). Hyperphosphorylated tau aggregates are also found in many neurodegenerative diseases, collectively referred to as "tauopathies," and tau mutations are associated with familial frontotemporal lobar degeneration (FTLD). Previous studies have generated transgenic mice with mutant tau as tauopathy models, but nonhuman primates, which are more similar to humans, may be a better model to study tauopathies. For example, the common marmoset is poised as a nonhuman primate model for investigating the etiology of age-related neurodegenerative diseases. However, no biochemical studies of tau have been conducted in marmoset brains. Here, we investigated several important aspects of tau, including expression of different tau isoforms and its phosphorylation status, in the marmoset brain. We found that marmoset tau does not possess the "primate-unique motif" in its N-terminal domain. We also discovered that the tau isoform expression pattern in marmosets is more similar to that of mice than that of humans, with adult marmoset brains expressing only four-repeat tau isoforms as in adult mice but unlike in adult human brains. Of note, tau in brains of marmoset newborns was phosphorylated at several sites associated with AD pathology. However, in adult marmoset brains, much of this phosphorylation was lost, except for Ser-202 and Ser-404 phosphorylation. These results reveal key features of tau expression and phosphorylation in the marmoset brain, a potentially useful nonhuman primate model of neurodegenerative diseases.
© 2019 Sharma et al.

Entities:  

Keywords:  Alzheimer disease; FTLD-tau; MAPT; alternative splicing; development; isoform; mammal; marmoset; neurodegeneration; neurodegenerative disease; non-human primate; phosphorylation; phylogenetics; tau protein (tau)

Mesh:

Substances:

Year:  2019        PMID: 31171723      PMCID: PMC6663862          DOI: 10.1074/jbc.RA119.008415

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.

Authors:  I D'Souza; G D Schellenberg
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

2.  Isoforms changes of tau protein during development in various species.

Authors:  Hiroshi Takuma; Shigeki Arawaka; Hiroshi Mori
Journal:  Brain Res Dev Brain Res       Date:  2003-05-14

3.  Primary structure of high molecular weight tau present in the peripheral nervous system.

Authors:  D Couchie; C Mavilia; I S Georgieff; R K Liem; M L Shelanski; J Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Phosphate-binding tag, a new tool to visualize phosphorylated proteins.

Authors:  Eiji Kinoshita; Emiko Kinoshita-Kikuta; Kei Takiyama; Tohru Koike
Journal:  Mol Cell Proteomics       Date:  2005-12-11       Impact factor: 5.911

5.  5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.

Authors:  A Grover; H Houlden; M Baker; J Adamson; J Lewis; G Prihar; S Pickering-Brown; K Duff; M Hutton
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

6.  Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition.

Authors:  Changiz Geula; Nicholas Nagykery; Chuang-Kuo Wu
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

7.  Neuropathological diagnostic criteria for Alzheimer's disease.

Authors:  Shigeo Murayama; Yuko Saito
Journal:  Neuropathology       Date:  2004-09       Impact factor: 1.906

8.  Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

Authors:  M Goedert; M G Spillantini; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Tau gene (MAPT) sequence variation among primates.

Authors:  Max Holzer; Molly Craxton; Ross Jakes; Thomas Arendt; Michel Goedert
Journal:  Gene       Date:  2004-10-27       Impact factor: 3.688

10.  Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.

Authors:  A-M Shiarli; R Jennings; J Shi; K Bailey; Y Davidson; J Tian; E H Bigio; B Ghetti; J R Murrell; M B Delisle; S Mirra; B Crain; P Zolo; K Arima; E Iseki; S Murayama; H Kretzschmar; M Neumann; C Lippa; G Halliday; J Mackenzie; N Khan; R Ravid; D Dickson; Z Wszolek; T Iwatsubo; S M Pickering-Brown; D M A Mann
Journal:  Neuropathol Appl Neurobiol       Date:  2006-08       Impact factor: 8.090

View more
  10 in total

1.  Evidence of traumatic brain injury in headbutting bovids.

Authors:  Nicole L Ackermans; Merina Varghese; Terrie M Williams; Nicholas Grimaldi; Enna Selmanovic; Akbar Alipour; Priti Balchandani; Joy S Reidenberg; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2022-05-17       Impact factor: 15.887

2.  Characterization of microtubule-associated protein tau isoforms and Alzheimer's disease-like pathology in normal sheep (Ovis aries): relevance to their potential as a model of Alzheimer's disease.

Authors:  Emma S Davies; Russell M Morphew; David Cutress; A Jennifer Morton; Sebastian McBride
Journal:  Cell Mol Life Sci       Date:  2022-10-21       Impact factor: 9.207

Review 3.  Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus).

Authors:  Brett M Frye; Suzanne Craft; Caitlin S Latimer; C Dirk Keene; Thomas J Montine; Thomas C Register; Miranda E Orr; Kylie Kavanagh; Shannon L Macauley; Carol A Shively
Journal:  Am J Primatol       Date:  2021-04-05       Impact factor: 2.371

4.  Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging.

Authors:  Angela O Dorigatti; Stacy A Hussong; Stephen F Hernandez; Aubrey M Sills; Adam B Salmon; Veronica Galvan
Journal:  Geroscience       Date:  2020-10-15       Impact factor: 7.713

5.  A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.

Authors:  Danielle Beckman; Paramita Chakrabarty; Sean Ott; Amanda Dao; Eric Zhou; William G Janssen; Kristine Donis-Cox; Scott Muller; Jeffrey H Kordower; John H Morrison
Journal:  Alzheimers Dement       Date:  2021-03-18       Impact factor: 21.566

Review 6.  Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.

Authors:  Ingrid H C H M Philippens; Jan A M Langermans
Journal:  Vaccines (Basel)       Date:  2021-04-15

Review 7.  The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer's Disease.

Authors:  Gail A Stonebarger; Heather A Bimonte-Nelson; Henryk F Urbanski
Journal:  Front Aging Neurosci       Date:  2021-09-03       Impact factor: 5.750

Review 8.  Comparative neuropathology in aging primates: A perspective.

Authors:  Carmen Freire-Cobo; Melissa K Edler; Merina Varghese; Emily Munger; Jessie Laffey; Sophia Raia; Selena S In; Bridget Wicinski; Maria Medalla; Sylvia E Perez; Elliott J Mufson; Joseph M Erwin; Elaine E Guevara; Chet C Sherwood; Jennifer I Luebke; Agnès Lacreuse; Mary A Raghanti; Patrick R Hof
Journal:  Am J Primatol       Date:  2021-07-13       Impact factor: 2.371

9.  Cross species application of quantitative neuropathology assays developed for clinical Alzheimer's disease samples.

Authors:  Silvan R Urfer; Caitlin S Latimer; Warren Ladiges; C Dirk Keene; Sarah Benbow; Benjamin Harrison; Daniel E L Promislow; Matt Kaeberlein; Brian C Kraemer; Adrienne Wang; Franco Guscetti; Martin Darvas
Journal:  Pathobiol Aging Age Relat Dis       Date:  2019-09-03

Review 10.  Microglia in Aging and Alzheimer's Disease: A Comparative Species Review.

Authors:  Melissa K Edler; Isha Mhatre-Winters; Jason R Richardson
Journal:  Cells       Date:  2021-05-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.